0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Narcolepsy Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-1A6271
Home | Market Reports | Health| Health Conditions| Sleep Disorders
Global Narcolepsy Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Narcolepsy Market Insights, Forecast to 2029

Code: QYRE-Auto-1A6271
Report
August 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Narcolepsy Market

Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
Market Analysis and Insights: Global Narcolepsy Market
The global Narcolepsy market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
Report Includes
This report presents an overview of global market for Narcolepsy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Narcolepsy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Narcolepsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Narcolepsy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Narcolepsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Narcolepsy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Jazz Pharmaceuticals, Bioprojet, Arena Pharmaceuticals, Graymark Healthcare, Mylan, Teva Pharmaceutical Industries, Novartis, Takeda and Shionogi, etc.

Scope of Narcolepsy Market Report

Report Metric Details
Report Name Narcolepsy Market
Segment by Type
  • Daytime Extreme Sleepiness
  • Cataplexia
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Jazz Pharmaceuticals, Bioprojet, Arena Pharmaceuticals, Graymark Healthcare, Mylan, Teva Pharmaceutical Industries, Novartis, Takeda, Shionogi, Ligand Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Narcolepsy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Narcolepsy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Narcolepsy revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Daytime Extreme Sleepiness
1.2.3 Cataplexia
1.2.4 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Market Perspective (2018-2029)
2.2 Global Narcolepsy Growth Trends by Region
2.2.1 Narcolepsy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Narcolepsy Historic Market Size by Region (2018-2023)
2.2.3 Narcolepsy Forecasted Market Size by Region (2024-2029)
2.3 Narcolepsy Market Dynamics
2.3.1 Narcolepsy Industry Trends
2.3.2 Narcolepsy Market Drivers
2.3.3 Narcolepsy Market Challenges
2.3.4 Narcolepsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Narcolepsy by Players
3.1.1 Global Narcolepsy Revenue by Players (2018-2023)
3.1.2 Global Narcolepsy Revenue Market Share by Players (2018-2023)
3.2 Global Narcolepsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Narcolepsy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Narcolepsy Market Concentration Ratio
3.4.1 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Revenue in 2022
3.5 Global Key Players of Narcolepsy Head office and Area Served
3.6 Global Key Players of Narcolepsy, Product and Application
3.7 Global Key Players of Narcolepsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Breakdown Data by Type
4.1 Global Narcolepsy Historic Market Size by Type (2018-2023)
4.2 Global Narcolepsy Forecasted Market Size by Type (2024-2029)
5 Narcolepsy Breakdown Data by Application
5.1 Global Narcolepsy Historic Market Size by Application (2018-2023)
5.2 Global Narcolepsy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Narcolepsy Market Size (2018-2029)
6.2 North America Narcolepsy Market Size by Type
6.2.1 North America Narcolepsy Market Size by Type (2018-2023)
6.2.2 North America Narcolepsy Market Size by Type (2024-2029)
6.2.3 North America Narcolepsy Market Share by Type (2018-2029)
6.3 North America Narcolepsy Market Size by Application
6.3.1 North America Narcolepsy Market Size by Application (2018-2023)
6.3.2 North America Narcolepsy Market Size by Application (2024-2029)
6.3.3 North America Narcolepsy Market Share by Application (2018-2029)
6.4 North America Narcolepsy Market Size by Country
6.4.1 North America Narcolepsy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Narcolepsy Market Size by Country (2018-2023)
6.4.3 North America Narcolepsy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Narcolepsy Market Size (2018-2029)
7.2 Europe Narcolepsy Market Size by Type
7.2.1 Europe Narcolepsy Market Size by Type (2018-2023)
7.2.2 Europe Narcolepsy Market Size by Type (2024-2029)
7.2.3 Europe Narcolepsy Market Share by Type (2018-2029)
7.3 Europe Narcolepsy Market Size by Application
7.3.1 Europe Narcolepsy Market Size by Application (2018-2023)
7.3.2 Europe Narcolepsy Market Size by Application (2024-2029)
7.3.3 Europe Narcolepsy Market Share by Application (2018-2029)
7.4 Europe Narcolepsy Market Size by Country
7.4.1 Europe Narcolepsy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Narcolepsy Market Size by Country (2018-2023)
7.4.3 Europe Narcolepsy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Narcolepsy Market Size (2018-2029)
8.2 China Narcolepsy Market Size by Type
8.2.1 China Narcolepsy Market Size by Type (2018-2023)
8.2.2 China Narcolepsy Market Size by Type (2024-2029)
8.2.3 China Narcolepsy Market Share by Type (2018-2029)
8.3 China Narcolepsy Market Size by Application
8.3.1 China Narcolepsy Market Size by Application (2018-2023)
8.3.2 China Narcolepsy Market Size by Application (2024-2029)
8.3.3 China Narcolepsy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Narcolepsy Market Size (2018-2029)
9.2 Asia Narcolepsy Market Size by Type
9.2.1 Asia Narcolepsy Market Size by Type (2018-2023)
9.2.2 Asia Narcolepsy Market Size by Type (2024-2029)
9.2.3 Asia Narcolepsy Market Share by Type (2018-2029)
9.3 Asia Narcolepsy Market Size by Application
9.3.1 Asia Narcolepsy Market Size by Application (2018-2023)
9.3.2 Asia Narcolepsy Market Size by Application (2024-2029)
9.3.3 Asia Narcolepsy Market Share by Application (2018-2029)
9.4 Asia Narcolepsy Market Size by Region
9.4.1 Asia Narcolepsy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Narcolepsy Market Size by Region (2018-2023)
9.4.3 Asia Narcolepsy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Narcolepsy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Narcolepsy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Narcolepsy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Narcolepsy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Narcolepsy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Narcolepsy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Narcolepsy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Narcolepsy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Narcolepsy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Narcolepsy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Narcolepsy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Narcolepsy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Narcolepsy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Details
11.1.2 Jazz Pharmaceuticals Business Overview
11.1.3 Jazz Pharmaceuticals Narcolepsy Introduction
11.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2018-2023)
11.1.5 Jazz Pharmaceuticals Recent Developments
11.2 Bioprojet
11.2.1 Bioprojet Company Details
11.2.2 Bioprojet Business Overview
11.2.3 Bioprojet Narcolepsy Introduction
11.2.4 Bioprojet Revenue in Narcolepsy Business (2018-2023)
11.2.5 Bioprojet Recent Developments
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Narcolepsy Introduction
11.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2018-2023)
11.3.5 Arena Pharmaceuticals Recent Developments
11.4 Graymark Healthcare
11.4.1 Graymark Healthcare Company Details
11.4.2 Graymark Healthcare Business Overview
11.4.3 Graymark Healthcare Narcolepsy Introduction
11.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2018-2023)
11.4.5 Graymark Healthcare Recent Developments
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Narcolepsy Introduction
11.5.4 Mylan Revenue in Narcolepsy Business (2018-2023)
11.5.5 Mylan Recent Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Narcolepsy Introduction
11.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2018-2023)
11.6.5 Teva Pharmaceutical Industries Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Narcolepsy Introduction
11.7.4 Novartis Revenue in Narcolepsy Business (2018-2023)
11.7.5 Novartis Recent Developments
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Narcolepsy Introduction
11.8.4 Takeda Revenue in Narcolepsy Business (2018-2023)
11.8.5 Takeda Recent Developments
11.9 Shionogi
11.9.1 Shionogi Company Details
11.9.2 Shionogi Business Overview
11.9.3 Shionogi Narcolepsy Introduction
11.9.4 Shionogi Revenue in Narcolepsy Business (2018-2023)
11.9.5 Shionogi Recent Developments
11.10 Ligand Pharmaceuticals
11.10.1 Ligand Pharmaceuticals Company Details
11.10.2 Ligand Pharmaceuticals Business Overview
11.10.3 Ligand Pharmaceuticals Narcolepsy Introduction
11.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2018-2023)
11.10.5 Ligand Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Narcolepsy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Daytime Extreme Sleepiness
    Table 3. Key Players of Cataplexia
    Table 4. Key Players of Others
    Table 5. Global Narcolepsy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 6. Global Narcolepsy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Narcolepsy Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Narcolepsy Market Share by Region (2018-2023)
    Table 9. Global Narcolepsy Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Narcolepsy Market Share by Region (2024-2029)
    Table 11. Narcolepsy Market Trends
    Table 12. Narcolepsy Market Drivers
    Table 13. Narcolepsy Market Challenges
    Table 14. Narcolepsy Market Restraints
    Table 15. Global Narcolepsy Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Narcolepsy Revenue Share by Players (2018-2023)
    Table 17. Global Top Narcolepsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy as of 2022)
    Table 18. Global Narcolepsy Industry Ranking 2021 VS 2022 VS 2023
    Table 19. Global 5 Largest Players Market Share by Narcolepsy Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Global Key Players of Narcolepsy, Headquarters and Area Served
    Table 21. Global Key Players of Narcolepsy, Product and Application
    Table 22. Global Key Players of Narcolepsy, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Narcolepsy Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Narcolepsy Revenue Market Share by Type (2018-2023)
    Table 26. Global Narcolepsy Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Narcolepsy Revenue Market Share by Type (2024-2029)
    Table 28. Global Narcolepsy Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Narcolepsy Revenue Share by Application (2018-2023)
    Table 30. Global Narcolepsy Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Narcolepsy Revenue Share by Application (2024-2029)
    Table 32. North America Narcolepsy Market Size by Type (2018-2023) & (US$ Million)
    Table 33. North America Narcolepsy Market Size by Type (2024-2029) & (US$ Million)
    Table 34. North America Narcolepsy Market Size by Application (2018-2023) & (US$ Million)
    Table 35. North America Narcolepsy Market Size by Application (2024-2029) & (US$ Million)
    Table 36. North America Narcolepsy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. North America Narcolepsy Market Size by Country (2018-2023) & (US$ Million)
    Table 38. North America Narcolepsy Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Europe Narcolepsy Market Size by Type (2018-2023) & (US$ Million)
    Table 40. Europe Narcolepsy Market Size by Type (2024-2029) & (US$ Million)
    Table 41. Europe Narcolepsy Market Size by Application (2018-2023) & (US$ Million)
    Table 42. Europe Narcolepsy Market Size by Application (2024-2029) & (US$ Million)
    Table 43. Europe Narcolepsy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Europe Narcolepsy Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Europe Narcolepsy Market Size by Country (2024-2029) & (US$ Million)
    Table 46. China Narcolepsy Market Size by Type (2018-2023) & (US$ Million)
    Table 47. China Narcolepsy Market Size by Type (2024-2029) & (US$ Million)
    Table 48. China Narcolepsy Market Size by Application (2018-2023) & (US$ Million)
    Table 49. China Narcolepsy Market Size by Application (2024-2029) & (US$ Million)
    Table 50. Asia Narcolepsy Market Size by Type (2018-2023) & (US$ Million)
    Table 51. Asia Narcolepsy Market Size by Type (2024-2029) & (US$ Million)
    Table 52. Asia Narcolepsy Market Size by Application (2018-2023) & (US$ Million)
    Table 53. Asia Narcolepsy Market Size by Application (2024-2029) & (US$ Million)
    Table 54. Asia Narcolepsy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 55. Asia Narcolepsy Market Size by Region (2018-2023) & (US$ Million)
    Table 56. Asia Narcolepsy Market Size by Region (2024-2029) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Narcolepsy Market Size by Type (2018-2023) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Narcolepsy Market Size by Type (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Narcolepsy Market Size by Application (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Narcolepsy Market Size by Application (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Narcolepsy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 62. Middle East, Africa, and Latin America Narcolepsy Market Size by Country (2018-2023) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Narcolepsy Market Size by Country (2024-2029) & (US$ Million)
    Table 64. Jazz Pharmaceuticals Company Details
    Table 65. Jazz Pharmaceuticals Business Overview
    Table 66. Jazz Pharmaceuticals Narcolepsy Product
    Table 67. Jazz Pharmaceuticals Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 68. Jazz Pharmaceuticals Recent Developments
    Table 69. Bioprojet Company Details
    Table 70. Bioprojet Business Overview
    Table 71. Bioprojet Narcolepsy Product
    Table 72. Bioprojet Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 73. Bioprojet Recent Developments
    Table 74. Arena Pharmaceuticals Company Details
    Table 75. Arena Pharmaceuticals Business Overview
    Table 76. Arena Pharmaceuticals Narcolepsy Product
    Table 77. Arena Pharmaceuticals Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 78. Arena Pharmaceuticals Recent Developments
    Table 79. Graymark Healthcare Company Details
    Table 80. Graymark Healthcare Business Overview
    Table 81. Graymark Healthcare Narcolepsy Product
    Table 82. Graymark Healthcare Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 83. Graymark Healthcare Recent Developments
    Table 84. Mylan Company Details
    Table 85. Mylan Business Overview
    Table 86. Mylan Narcolepsy Product
    Table 87. Mylan Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 88. Mylan Recent Developments
    Table 89. Teva Pharmaceutical Industries Company Details
    Table 90. Teva Pharmaceutical Industries Business Overview
    Table 91. Teva Pharmaceutical Industries Narcolepsy Product
    Table 92. Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 93. Teva Pharmaceutical Industries Recent Developments
    Table 94. Novartis Company Details
    Table 95. Novartis Business Overview
    Table 96. Novartis Narcolepsy Product
    Table 97. Novartis Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 98. Novartis Recent Developments
    Table 99. Takeda Company Details
    Table 100. Takeda Business Overview
    Table 101. Takeda Narcolepsy Product
    Table 102. Takeda Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 103. Takeda Recent Developments
    Table 104. Shionogi Company Details
    Table 105. Shionogi Business Overview
    Table 106. Shionogi Narcolepsy Product
    Table 107. Shionogi Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 108. Shionogi Recent Developments
    Table 109. Ligand Pharmaceuticals Company Details
    Table 110. Ligand Pharmaceuticals Business Overview
    Table 111. Ligand Pharmaceuticals Narcolepsy Product
    Table 112. Ligand Pharmaceuticals Revenue in Narcolepsy Business (2018-2023) & (US$ Million)
    Table 113. Ligand Pharmaceuticals Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Narcolepsy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Narcolepsy Market Share by Type: 2022 VS 2029
    Figure 3. Daytime Extreme Sleepiness Features
    Figure 4. Cataplexia Features
    Figure 5. Others Features
    Figure 6. Global Narcolepsy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 7. Global Narcolepsy Market Share by Application: 2022 VS 2029
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Narcolepsy Report Years Considered
    Figure 12. Global Narcolepsy Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Narcolepsy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Narcolepsy Market Share by Region: 2022 VS 2029
    Figure 15. Global Narcolepsy Market Share by Players in 2022
    Figure 16. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Narcolepsy Revenue in 2022
    Figure 18. North America Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Narcolepsy Market Share by Type (2018-2029)
    Figure 20. North America Narcolepsy Market Share by Application (2018-2029)
    Figure 21. North America Narcolepsy Market Share by Country (2018-2029)
    Figure 22. United States Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Narcolepsy Market Size YoY (2018-2029) & (US$ Million)
    Figure 25. Europe Narcolepsy Market Share by Type (2018-2029)
    Figure 26. Europe Narcolepsy Market Share by Application (2018-2029)
    Figure 27. Europe Narcolepsy Market Share by Country (2018-2029)
    Figure 28. Germany Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. France Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. U.K. Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Italy Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Russia Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Nordic Countries Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. China Narcolepsy Market Size YoY (2018-2029) & (US$ Million)
    Figure 35. China Narcolepsy Market Share by Type (2018-2029)
    Figure 36. China Narcolepsy Market Share by Application (2018-2029)
    Figure 37. Asia Narcolepsy Market Size YoY (2018-2029) & (US$ Million)
    Figure 38. Asia Narcolepsy Market Share by Type (2018-2029)
    Figure 39. Asia Narcolepsy Market Share by Application (2018-2029)
    Figure 40. Asia Narcolepsy Market Share by Region (2018-2029)
    Figure 41. Japan Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. South Korea Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. China Taiwan Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. India Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Australia Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Narcolepsy Market Size YoY (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Narcolepsy Market Share by Type (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Narcolepsy Market Share by Application (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Narcolepsy Market Share by Country (2018-2029)
    Figure 51. Brazil Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Mexico Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Turkey Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Israel Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. GCC Countries Narcolepsy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Jazz Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 58. Bioprojet Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 59. Arena Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 60. Graymark Healthcare Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 61. Mylan Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 63. Novartis Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 64. Takeda Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 65. Shionogi Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 66. Ligand Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2018-2023)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS